Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-12

Clinical Trial Update: Tiotropium/Salmeterol/Fluticasone Fixed Dose Combination Tratment Via Discair vs Tiotropium Via Handihaler + Salmeterol/Fluticasone Via Diskus Free Combination Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial comparing a fixed-dose combination inhaler (tiotropium/salmeterol/fluticasone) to separate tiotropium plus salmeterol/fluticasone in COPD patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Salmeterol/Fluticasone (fluticasone propionate/salmeterol)
  • Tiotropium/Salmeterol/Fluticasone
  • tiotropium (tiotropium)

Snippet

Sponsor: Neutec Ar-Ge San ve Tic A.Ş | Conditions: COPD | Phase 4 | Status: COMPLETED